ARCHIVES

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

This article is from The Cancer Letter archive.

Vol. 04 No. 47 | November 24, 1978

Download PDF Visit The Full Archive

Related Articles

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013